About Andros Medicines
Andros Medicines is a private company based in Boston, Massachusetts, incorporated in 2026 in Delaware. It has reported $3,049,999 raised in one offering on Form D since July 2026. Its chief executive is John Maraganore.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jul 1, 2026 | $3,049,999of $5.0M target | 2 | $1.5M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Andros Medicines's Form D filed Jul 1, 2026.